Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125377221 | 12537722 | 1 | I | 20160403 | 20160629 | 20160707 | 20160707 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-054054 | BRISTOL MYERS SQUIBB | 84.13 | YR | M | Y | 0.00000 | 20160707 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125377221 | 12537722 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | UNK | Y | 202155 | FILM-COATED TABLET | ||||||||
125377221 | 12537722 | 2 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, QD | Y | 0 | 75 | MG | QD | ||||||
125377221 | 12537722 | 3 | C | ALFUZOSIN | ALFUZOSIN | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 7 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 9 | C | MIANSERIN | MIANSERIN | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
125377221 | 12537722 | 11 | C | PRAZEPAM | PRAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125377221 | 12537722 | 1 | Cerebrovascular accident prophylaxis |
125377221 | 12537722 | 2 | Product used for unknown indication |
125377221 | 12537722 | 3 | Product used for unknown indication |
125377221 | 12537722 | 4 | Product used for unknown indication |
125377221 | 12537722 | 5 | Product used for unknown indication |
125377221 | 12537722 | 6 | Product used for unknown indication |
125377221 | 12537722 | 7 | Product used for unknown indication |
125377221 | 12537722 | 8 | Product used for unknown indication |
125377221 | 12537722 | 9 | Product used for unknown indication |
125377221 | 12537722 | 10 | Product used for unknown indication |
125377221 | 12537722 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125377221 | 12537722 | OT |
125377221 | 12537722 | HO |
125377221 | 12537722 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125377221 | 12537722 | Acute kidney injury | |
125377221 | 12537722 | Hepatic haematoma | |
125377221 | 12537722 | Shock haemorrhagic | |
125377221 | 12537722 | Transfusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125377221 | 12537722 | 1 | 20160401 | 20160403 | 0 | |
125377221 | 12537722 | 2 | 20160403 | 0 |